EREG and hepatocellular carcinoma: Our data demonstrated that EREG acts as a mediator for cellular interactions between HCC and activated HSCs to accelerate HCC development by inducing cancer cell proliferation, migration/invasion, and tumor neovascularization during stimulation with LPS.